Information disclosure in Oracle Life Sciences Central Designer
CVE-2026-21974
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Vulnerability class: Information Disclosure
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.
EPSS exploit prediction
EPSS 0.003, 17.2th percentile (last changed ); unchanged over 30 days. About EPSS.
Affected products
- Oracle Life Sciences Central Designer — versions 7.0.1.0
- Oracle Corporation Life Sciences Central Designer — versions 7.0.1.0
Weakness classification (CWE)
References
- Oracle Advisory (vendor-advisory, Vendor Advisory)